Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Flournoy

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|March 25, 1995
Do small trials square with large ones?N Flournoy, I Olkin
Reviews of Infectious Diseases|November 1, 1982
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experienceJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|March 1, 1986
Risk factors for cytomegalovirus infection after human marrow transplantationJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|December 1, 1980
Cytomegalovirus infection and specific cell-mediated immunity after marrow transplantJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|April 1, 1980
Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplantJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|September 1, 1980
Infection with herpes simplex virus and cell-mediated immunity after marrow transplantJ D Meyers, N Flournoy, E D Thomas
Biometrics|June 1, 1997
A random walk rule for phase I clinical trialsS D Durham, N Flournoy, W F Rosenberger
Cancer|November 15, 1985
Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trialJ Mortimer, N Flournoy, R B Livingston, et al.
Annals of Internal Medicine|June 1, 1984
Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantationJ C Wade, B Newton, N Flournoy, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantationD H Shepp, P S Dandliker, N Flournoy, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|March 25, 1995
Do small trials square with large ones?N Flournoy, I Olkin
Reviews of Infectious Diseases|November 1, 1982
Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experienceJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|March 1, 1986
Risk factors for cytomegalovirus infection after human marrow transplantationJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|December 1, 1980
Cytomegalovirus infection and specific cell-mediated immunity after marrow transplantJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|April 1, 1980
Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplantJ D Meyers, N Flournoy, E D Thomas
The Journal of Infectious Diseases|September 1, 1980
Infection with herpes simplex virus and cell-mediated immunity after marrow transplantJ D Meyers, N Flournoy, E D Thomas
Biometrics|June 1, 1997
A random walk rule for phase I clinical trialsS D Durham, N Flournoy, W F Rosenberger
Cancer|November 15, 1985
Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trialJ Mortimer, N Flournoy, R B Livingston, et al.
Annals of Internal Medicine|June 1, 1984
Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantationJ C Wade, B Newton, N Flournoy, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1985
Once-daily intravenous acyclovir for prophylaxis of herpes simplex virus reactivation after marrow transplantationD H Shepp, P S Dandliker, N Flournoy, et al.
Pageof 6